IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Svennilson Peter

Q4 2019 Holdings

Filed 2020-02-12 | 7 holdings | $36.6M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Arcus Biosciences Inc(RCUS)COM03969F109$35.8M3,540,85097.8%
NGM Biopharmaceuticals Inc(NGMUSD)COM62921N105$303.6K16,420,8290.8%
Constellation Pharmceticls I(CNST)COM210373106$283.1K6,009,7020.8%
Rapt Therapeutics Inc(RAPTEUR)COM75382E109$187.1K6,777,1510.5%
Gritstone Oncology Inc(2JQ)COM39868T105$27.8K3,102,9340.1%